Snowball logo
logo
  • Stocks
  • China
  • Healthcare
3010

Medprin Regenerative Medical Technologies Co. Ltd.

301033 • SHE
¥59.72¥0.00  (0%)
Estimate
P/E
36.4
EPS
1.64
Beta
0.029
Growth
Revenue, YoY
-10.44%
Net income, YoY
-20.48%
FCF, YoY
-110.37%
Dividends
Dividend yield
1.17%
Annual payout
¥0.70
Next ex. div date
June 1, 27
Payout
0%
Dividend growth streak
4 y
Div.rating
About the company
Ticker
301033
ISIN
CNE100004NB8
Country
China
Sector (GICS)
Healthcare
Medprin Regenerative Medical Technologies Co., Ltd. engages in the research and development, manufacture, and sale of implantable medical devices in China and internationally. The company offers artificial dura mater patches, craniofacial repair and fixation systems, and absorbable regenerative oxidation for neurosurgery meningeal repair, skull repair fixation and rapid hemostasis, etc. It also offers ReDura, a Synthetic Dural Substitute; NeoDura, a novel dural patch; Recranio, a Cranio-Maxillofacial repair system; and StypCel, an Absorbable Hemostat; Immiseal, a dural sealant system; and 3D bioprinting applications serving patients internationally. Medprin Regenerative Medical Technologies Co., Ltd. was founded in 2008 and is headquartered in Guangzhou, China.

Frequently asked questions

What sector does Medprin Regenerative Medical Technologies Co. Ltd. (301033) operate in?

Medprin Regenerative Medical Technologies Co. Ltd. belongs to the Healthcare sector and operates in the Medical Devices industry.

What is Medprin Regenerative Medical Technologies Co. Ltd. (301033) current stock price?

As of the latest data, Medprin Regenerative Medical Technologies Co. Ltd. stock price is CN¥59.72, with a previous close of CN¥59.72.

What is Medprin Regenerative Medical Technologies Co. Ltd. (301033) current market capitalization?

Medprin Regenerative Medical Technologies Co. Ltd. market cap is approximately 4.00 billion.

What is Medprin Regenerative Medical Technologies Co. Ltd. (301033) Earnings Per Share (EPS)?

The trailing EPS is CN¥1.64.

What is Medprin Regenerative Medical Technologies Co. Ltd. (301033) Price-to-Earnings (P/E) ratio?

Medprin Regenerative Medical Technologies Co. Ltd. current P/E ratio is 36.41.

Does Medprin Regenerative Medical Technologies Co. Ltd. (301033) pay dividends?

Yes. Medprin Regenerative Medical Technologies Co. Ltd. pays annual dividends with an annualized yield of 1.17% and an estimated annual payout of CN¥0.70 per share.

When is the next ex-dividend date for Medprin Regenerative Medical Technologies Co. Ltd. (301033)?

The next ex-dividend date is scheduled for June 01, 2027.

What is Medprin Regenerative Medical Technologies Co. Ltd. (301033) beta (volatility) score?

Medprin Regenerative Medical Technologies Co. Ltd. has a beta of 0.029, indicating lower volatility than the overall market.
2026 © Snowball Analytics
𝕏
Snowball Analytics SAS914 331 640 R.C.S. LYON
Greffe du tribunal de Commerce de LYONAddress: LE FORUM 27 RUE MAURICE FLANDIN
LYON CEDEX 3, 69444, FranceEmail: [email protected]
Get the Snowball Analytics app
Download Snowball Analytics on App Store
4.8 • 4600ratings
Download Snowball Analytics on Google Play
4.8 • 2500ratings
Powered by EODHD, SnapTrade
ProductPortfolio trackerStock trackerDividend trackerDividend calendarDividend calculatorsSharesight vs. Dividend.Watch vs. Snowball AnalyticsPricing
ResourcesTerms and conditionsPrivacy policySecurityYodleeAbout usContacts
Support Support Knowledge Base
Snowball Analytics would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The site and content, are provided “as is” and without warranties of any kind. You bear all risks associated with the use of the site and content, including without limitation, any reliance on the accuracy, completeness or usefulness of any content available on the site. The Website should not be relied upon as a substitute for extensive independent market research before making your actual trading decisions. Past performance is not an indicator of future performance. Snowball Analytics is not a registered investment advisor or broker/dealer. Any opinions, charts, messages, news, research, analyses, prices, or other information contained on this Website are provided as general market information for educational and entertainment purposes only, and do not constitute investment advice.
Interactive Brokers is not affiliated with Snowball Analytics and does not endorse or recommend any information or advice provided by Snowball Analytics.